{"id":109931,"date":"2024-10-28T13:04:34","date_gmt":"2024-10-28T10:04:34","guid":{"rendered":"https:\/\/avicennaint.com\/?p=109931"},"modified":"2024-10-28T13:04:35","modified_gmt":"2024-10-28T10:04:35","slug":"neuroendocrine-tumours-treatment-in-turkey","status":"publish","type":"post","link":"https:\/\/avicennaint.com\/en\/neuroendocrine-tumours-treatment-in-turkey\/","title":{"rendered":"Neuroendocrine Tumours Treatment in Turkey"},"content":{"rendered":"\n

Neuroendocrine tumour treatment in Turkey<\/strong> has emerged as a beacon of hope for many patients around the globe, primarily due to state-of-the-art medical facilities and cost-effective care. Neuroendocrine tumours (NETs) are rare and can develop in various organs. They impact the neuroendocrine cells that release hormones into the bloodstream, with most of them being malignant. Understanding the complexities of neuroendocrine tumours involves recognizing their types, symptoms, causes, and treatment options that are meticulously carried out in Turkey\u2019s medical institutions.<\/p>\n\n\n\n

What is a Neuroendocrine Tumor (NET)?<\/h2>\n\n\n\n

Neuroendocrine tumours are a diverse set of uncommon neoplasms originating from neuroendocrine cells, combining traits of both nerve cells and hormone-producing endocrine cells. These tumours can deceptively mimic symptoms of less severe conditions due to their varying aggressive nature. The symptoms of neuroendocrine cancer, such as severe fatigue, organ dysfunction, and intense neuroendocrine cancer back pain, can be particularly distressing.<\/p>\n\n\n\n

Types of Neuroendocrine Tumors<\/h2>\n\n\n\n

NETs are classified based on hormone release: Functional NETs cause hormone-related symptoms, while non-functional ones can cause symptoms by impacting organs. The most prevalent types include gastrointestinal neuroendocrine tumours (GI-NETs), lung neuroendocrine tumours, and pancreatic neuroendocrine tumours (P-NETs). Less frequently, NETs may originate in the thyroid, parathyroid, pituitary, adrenal glands, and thymus.<\/p>\n\n\n\n

How Common are Neuroendocrine Tumors?<\/h2>\n\n\n\n

Globally affecting about 6 people in 100,000, neuroendocrine tumours have seen a rise in diagnoses due to advances in diagnostic techniques. While NETs can develop at any age, they are predominantly diagnosed in individuals aged between 50 and 60.<\/p>\n\n\n\n

Symptoms and Causes<\/h2>\n\n\n\n

Neuroendocrine tumours often remain asymptomatic until they significantly impact an organ, causing varied symptoms such as fatigue, stomach pain, or respiratory issues. The exact cause of NETs remains unclear, although they are linked to rare inherited syndromes involving gene mutations.<\/p>\n\n\n\n

Risk Factors<\/h2>\n\n\n\n

Certain genetic conditions like multiple endocrine neoplasia (MEN), Von Hippel-Lindau syndrome, and neurofibromatosis type 1 significantly elevate the risk of developing NETs. Detailed family history and genetic counselling form part of comprehensive care in Turkey.<\/p>\n\n\n\n

Diagnosing Neuroendocrine Tumours<\/h2>\n\n\n\n

In Turkey, diagnosing NETs involves extensive blood and urine tests, imaging scans like CT, MRI, PET, and specialized octreotide scans, coupled with biopsy procedures. These techniques ensure precise detection and staging of the tumour, aiding in the formulation of an effective treatment plan.<\/p>\n\n\n\n

Treatment for Neuroendocrine Tumours<\/h2>\n\n\n\n

The treatment of neuroendocrine tumours in Turkey is tailored based on the tumour\u2019s location, stage, and patient health, often involving surgery to excise the tumour, especially when it has not metastasized. Non-surgical options include somatostatin analogues to manage hormone overproduction, chemotherapy, radiotherapy, and advanced techniques like radiofrequency ablation. Targeted drug therapies and peptide receptor radionuclide therapy (PRRT), particularly Lutathera, are also employed for advanced cases. While some patients inquire about “how bad is neuroendocrine cancer” or “what is the best treatment for neuroendocrine cancer,” treatment in Turkey covers options tailored to the individual.<\/p>\n\n\n\n

Staging Neuroendocrine Tumors<\/h2>\n\n\n\n

Staging in Turkey adheres to internationally recognized systems, such as the TNM system (Tumor, Node, Metastasis), which classifies NETs based on the size and location of the primary tumour (T), the involvement of lymph nodes (N), and the presence of distant metastasis (M). However, the specific staging criteria can vary based on the primary location of the NET. For instance, a pancreatic NET will have a different staging system compared to a gastrointestinal NET. In Turkey, specialists assess these factors to assign a precise stage (usually I-IV, with higher numbers indicating more advanced disease), which influences the subsequent treatment strategy.<\/p>\n\n\n\n